Viking Therapeutics (1VT.STU) Q2 2026 Earnings

29AprConfirmed
Q1 2026
Q2 2026
-1.17
-1.03
-0.89
-0.75

Details

Expected EPS
-0.83536621728
Actual EPS
-1.1731036000000001
Surprise EPS
-0.34
Surprise Percent
+40.43%

Description

Viking Therapeutics (1VT.STU) has reported earnings of -1.1731036000000001 per share for Q2 2026.

0 Comments

Share your thoughts